{
    "organizations": [],
    "uuid": "e532d073d2dd5e5d4ee040575b74b59ad59a45c5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-qianjiang-yongan-pharmaceutical-sa/brief-qianjiang-yongan-pharmaceutical-says-capital-management-firm-cuts-stake-in-co-to-6-6-pct-from-11-2-pct-idUSL4N1PJ2KN",
    "ord_in_thread": 0,
    "title": "BRIEF-Qianjiang Yongan Pharmaceutical says capital management firm cuts stake in co to 6.6 pct from 11.2 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - Qianjiang Yongan Pharmaceutical Co Ltd\n* Says a Shenzhen-based capital management firm cut stake in the co to 6.6 percent(13 million shares) from 11.2 percent (21.9 million shares), during the period from Aug. 4, 2017 to Jan. 18, 2018\nSource text in Chinese: goo.gl/VgA2ay\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-24T14:48:00.000+02:00",
    "crawled": "2018-01-25T13:03:19.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "qianjiang",
        "yongan",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "capital",
        "management",
        "firm",
        "cut",
        "stake",
        "co",
        "percent",
        "million",
        "share",
        "percent",
        "million",
        "share",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}